0

November 14, 2013 AT 9:00 am

Organovo Achieves One Month Performance, Drug Responsiveness for 3D Bioprinted Liver Tissues #3DThursday #3DPrinting

Fast Company Organovo photo 2

Organovo Achieves One Month Performance, Drug Responsiveness for 3D Bioprinted Liver Tissues:

Building on data first presented at the Experimental Biology conference in April 2013, the company presented data demonstrating retention of key liver functions in bioprinted tissues for up to 40 days, longer than one month.  Additional data presented at the Cell Therapy Bioprocessing Conference demonstrated that Organovo’s 3D liver tissues exhibit dose-dependent responses to acetaminophen, a known liver toxicant, and that the toxic effects can be assessed using both standard screening assays and histopathological assessment of the treated tissue.  The data demonstrate that Organovo’s 3D Liver tissue can potentially have value in assessing toxicology problems in human liver over a long period, including sub-acute and multiple dose effects. 

“This additional functional validation of Organovo’s 3D Liver continues the demonstration of strong performance of these tissues,” said Keith Murphy, Organovo’s chief executive officer.  “In April we were able to show that liver function was retained in our 3D Liver for over five days, and we have now demonstrated that our tissues perform consistently for at least 40 days, a significant improvement over the average 48 hour performance of 2D cultures.  The stable, liver-specific functionality of 3D Liver is consistent with our observations that other NovoGen bioprinted tissues become fully cellular, steady state, living tissues that persist over time.  Furthermore, the fact that these tissues demonstrate similar activity to native liver when presented with a known challenge drug is an encouraging indication of utility in drug development.”

The demonstration of extended function in Organovo’s 3D liver tissues was achieved faster than Organovo’s projected timeline of achieving these results by the end of 2013 and highlights progress in the development of a 3D Human Liver product, which is on track for launch in 2014. The company believes that a multi-cellular bioprinted 3D Liver system with extended life span in culture can provide superior results to current human cellular models and offer significant value to pharmaceutical researchers by enabling assessment of both biochemical and tissue responses….

Read more.


649-1
Every Thursday is #3dthursday here at Adafruit! The DIY 3D printing community has passion and dedication for making solid objects from digital models. Recently, we have noticed electronics projects integrated with 3D printed enclosures, brackets, and sculptures, so each Thursday we celebrate and highlight these bold pioneers!

Have you considered building a 3D project around an Arduino or other microcontroller? How about printing a bracket to mount your Raspberry Pi to the back of your HD monitor? And don’t forget the countless LED projects that are possible when you are modeling your projects in 3D!

The Adafruit Learning System has dozens of great tools to get you well on your way to creating incredible works of engineering, interactive art, and design with your 3D printer! If you’ve made a cool project that combines 3D printing and electronics, be sure to let us know, and we’ll feature it here!


Check out all the Circuit Playground Episodes! Our new kid’s show and subscribe!

Have an amazing project to share? Join the SHOW-AND-TELL every Wednesday night at 7:30pm ET on Google+ Hangouts.

Join us every Wednesday night at 8pm ET for Ask an Engineer!

Learn resistor values with Mho’s Resistance or get the best electronics calculator for engineers “Circuit Playground”Adafruit’s Apps!


Maker Business — TechShop is closed, files bankruptcy

Wearables — Don’t shy away from intricacy

Electronics — Are you grounded?

Biohacking — Learning to See with Sound

Get the only spam-free daily newsletter about wearables, running a "maker business", electronic tips and more! Subscribe at AdafruitDaily.com !



No Comments

No comments yet.

Sorry, the comment form is closed at this time.